Quantum BioPharma Ltd.
QNTM
$30.18
$4.4517.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.37% | -44.26% | |||
| Depreciation & Amortization | 14.98% | -6.62% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -45.56% | 49.27% | |||
| Operating Income | 45.56% | -49.27% | |||
| Income Before Tax | -60.18% | -35.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -60.18% | -35.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 70.00% | -48.99% | |||
| Net Income | -60.00% | -40.06% | |||
| EBIT | 45.56% | -49.27% | |||
| EBITDA | 46.68% | -50.93% | |||
| EPS Basic | -28.13% | 35.13% | |||
| Normalized Basic EPS | -14.93% | 24.98% | |||
| EPS Diluted | -28.13% | 35.13% | |||
| Normalized Diluted EPS | -14.93% | 24.98% | |||
| Average Basic Shares Outstanding | 24.89% | 115.93% | |||
| Average Diluted Shares Outstanding | 24.89% | 115.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||